Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Long-Term Deferred Tax (2019 - 2021)

Historic Long-Term Deferred Tax for Legend Biotech (LEGN) over the last 3 years, with Q4 2021 value amounting to $22.8 million.

  • Legend Biotech's Long-Term Deferred Tax fell 2597.64% to $22.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $22.8 million, marking a year-over-year decrease of 2597.64%. This contributed to the annual value of $22.8 million for FY2021, which is 2597.64% down from last year.
  • According to the latest figures from Q4 2021, Legend Biotech's Long-Term Deferred Tax is $22.8 million, which was down 2597.64% from $30.8 million recorded in Q4 2020.
  • In the past 5 years, Legend Biotech's Long-Term Deferred Tax ranged from a high of $30.8 million in Q4 2020 and a low of $5.7 million during Q4 2019
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $22.8 million (2021), whereas its average is $19.8 million.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first surged by 43885.58% in 2020, then tumbled by 2597.64% in 2021.
  • Over the past 3 years, Legend Biotech's Long-Term Deferred Tax (Quarter) stood at $5.7 million in 2019, then soared by 438.86% to $30.8 million in 2020, then dropped by 25.98% to $22.8 million in 2021.
  • Its Long-Term Deferred Tax was $22.8 million in Q4 2021, compared to $30.8 million in Q4 2020 and $5.7 million in Q4 2019.